Literature DB >> 21037562

Clinical trials: Tight control in early RA pays off in the long run.

David L Scott1, Anna Kowalczyk.   

Abstract

Clinical trials demonstrate that intensive treatment of early rheumatoid arthritis with a combination of DMARDs improves short-term outcomes. an extension study from a pivotal trial has now shown that such intensive early therapy can achieve a reduction in the rate of erosive progression over a period of 11 years.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21037562     DOI： 10.1038/nrrheum.2010.174

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

1.  Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.

Authors:  T Möttönen; P Hannonen; M Leirisalo-Repo; M Nissilä; H Kautiainen; M Korpela; L Laasonen; H Julkunen; R Luukkainen; K Vuori; L Paimela; H Blåfield; M Hakala; K Ilva; U Yli-Kerttula; K Puolakka; P Järvinen; M Hakola; H Piirainen; J Ahonen; I Pälvimäki; S Forsberg; K Koota; C Friman
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

2.  Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.

Authors:  Axel Finckh; Nick Bansback; Carlo A Marra; Aslam H Anis; Kaleb Michaud; Stanley Lubin; Marc White; Sonia Sizto; Matthew H Liang
Journal:  Ann Intern Med       Date:  2009-11-03       Impact factor: 25.391

3.  Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.

Authors:  Yvonne P M Goekoop-Ruiterman; Jeska K de Vries-Bouwstra; Cornelia F Allaart; Derkjen van Zeben; Pit J S M Kerstens; J Mieke W Hazes; Aelko H Zwinderman; André J Peeters; Johanna M de Jonge-Bok; Constant Mallée; Wim M de Beus; Peter B J de Sonnaville; Jacques A P M Ewals; Ferdinand C Breedveld; Ben A C Dijkmans
Journal:  Ann Intern Med       Date:  2007-03-20       Impact factor: 25.391

Review 4.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maxime Dougados; Paul Emery; Cecile Gaujoux-Viala; Simone Gorter; Rachel Knevel; Jackie Nam; Monika Schoels; Daniel Aletaha; Maya Buch; Laure Gossec; Tom Huizinga; Johannes W J W Bijlsma; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Cem Gabay; Juan Gomez-Reino; Marios Kouloumas; Tore K Kvien; Emilio Martin-Mola; Iain McInnes; Karel Pavelka; Piet van Riel; Marieke Scholte; David L Scott; Tuulikki Sokka; Guido Valesini; Ronald van Vollenhoven; Kevin L Winthrop; John Wong; Angela Zink; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

5.  Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.

Authors:  Lilian H D van Tuyl; Maarten Boers; Willem F Lems; Robert B Landewé; Huub Han; S van der Linden; Mart van de Laar; Rene Westhovens; J Christiaan van Denderen; Marie-Louise Westedt; André J Peeters; Piet Jacobs; Tom W J Huizinga; Hans van de Brink; Ben A C Dijkmans; Alexandre E Voskuyl
Journal:  Ann Rheum Dis       Date:  2009-05-17       Impact factor: 19.103

Review 6.  Joint damage and disability in rheumatoid arthritis: an updated systematic review.

Authors:  D L Scott; C Smith; G Kingsley
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

Review 7.  A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Authors:  Margaret H Y Ma; Gabrielle H Kingsley; David L Scott
Journal:  Rheumatology (Oxford)       Date:  2009-11-16       Impact factor: 7.580

8.  Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.

Authors:  Vappu Rantalaiho; Markku Korpela; Leena Laasonen; Hannu Kautiainen; Salme Järvenpää; Pekka Hannonen; Marjatta Leirisalo-Repo; Harri Blåfield; Kari Puolakka; Anna Karjalainen; Timo Möttönen
Journal:  Arthritis Res Ther       Date:  2010-06-24       Impact factor: 5.156

Review 9.  Transcription profiling of rheumatic diseases.

Authors:  Lisa G M van Baarsen; Carina L Bos; Tineke C T M van der Pouw Kraan; Cornelis L Verweij
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

10.  Management of rheumatoid arthritis: summary of NICE guidance.

Authors:  Chris Deighton; Rachel O'Mahony; Jonathan Tosh; Claire Turner; Michael Rudolf
Journal:  BMJ       Date:  2009-03-16
  10 in total
  1 in total

Review 1.  B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.

Authors:  Ozlem Pala; Alain Diaz; Bonnie B Blomberg; Daniela Frasca
Journal:  Clin Ther       Date:  2018-05-23       Impact factor: 3.393
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.